HealthEquity, Inc. $HQY Shares Sold by Motley Fool Wealth Management LLC

Motley Fool Wealth Management LLC cut its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 9.5% during the 2nd quarter, Holdings Channel reports. The firm owned 113,555 shares of the company’s stock after selling 11,912 shares during the period. Motley Fool Wealth Management LLC’s holdings in HealthEquity were worth $11,896,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Farther Finance Advisors LLC grew its position in shares of HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after purchasing an additional 172 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in shares of HealthEquity in the second quarter valued at approximately $33,000. WPG Advisers LLC acquired a new stake in shares of HealthEquity in the first quarter valued at approximately $28,000. Cullen Frost Bankers Inc. grew its position in shares of HealthEquity by 172.3% in the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after purchasing an additional 224 shares during the last quarter. Finally, Sellwood Investment Partners LLC acquired a new stake in shares of HealthEquity in the second quarter valued at approximately $58,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction that occurred on Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the transaction, the executive vice president owned 79,456 shares of the company’s stock, valued at $7,477,604.16. This trade represents a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president directly owned 49,795 shares of the company’s stock, valued at $4,392,416.95. The trade was a 3.45% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 9,281 shares of company stock worth $859,867. 1.50% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have recently commented on HQY shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. JPMorgan Chase & Co. upped their price objective on shares of HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, September 3rd. Barrington Research reissued an “outperform” rating and set a $125.00 price objective on shares of HealthEquity in a research note on Friday, August 29th. Royal Bank Of Canada upped their price objective on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. Finally, KeyCorp reduced their price objective on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, HealthEquity has an average rating of “Moderate Buy” and an average target price of $121.31.

HealthEquity Stock Performance

Shares of HQY opened at $96.17 on Tuesday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The company has a market capitalization of $8.29 billion, a price-to-earnings ratio of 58.29, a PEG ratio of 1.39 and a beta of 0.47. The company’s 50 day simple moving average is $92.34 and its 200 day simple moving average is $94.76. HealthEquity, Inc. has a 1 year low of $74.07 and a 1 year high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.92. The company had revenue of $325.80 million for the quarter, compared to the consensus estimate of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. On average, sell-side analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.